BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 16372799)

  • 1. Pyoderma gangrenosum.
    Conrad C; Trüeb RM
    J Dtsch Dermatol Ges; 2005 May; 3(5):334-42. PubMed ID: 16372799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
    Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
    Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical management of pyoderma gangrenosum.
    Wollina U
    Am J Clin Dermatol; 2002; 3(3):149-58. PubMed ID: 11978136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pyoderma gangrenosum].
    Herberger K
    Hautarzt; 2016 Sep; 67(9):753-63. PubMed ID: 27492434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pyoderma gangrenosum--a review.
    Wollina U
    Orphanet J Rare Dis; 2007 Apr; 2():19. PubMed ID: 17433111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pyoderma gangrenosum: case series].
    Richetta AG; Maiani E; Carboni V; Carlomagno V; Cimillo M; Mattozzi C; Calvieri S
    Clin Ter; 2007; 158(4):325-9. PubMed ID: 17953284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atypical pyoderma gangresosum in inflammatory bowel disease. A severe diagnostic challenge.
    Muñoz PS; Ugidos AF; Montiel PM; Yagüe TM; Garrido C; Herruzo JA
    Rev Esp Enferm Dig; 2009 Aug; 101(8):585-7. PubMed ID: 19785502
    [No Abstract]   [Full Text] [Related]  

  • 8. Autoinflammatory skin disorders in inflammatory bowel diseases, pyoderma gangrenosum and Sweet's syndrome: a comprehensive review and disease classification criteria.
    Marzano AV; Ishak RS; Saibeni S; Crosti C; Meroni PL; Cugno M
    Clin Rev Allergy Immunol; 2013 Oct; 45(2):202-10. PubMed ID: 23334898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case of refractory pyoderma gangrenosum treated with a combination of Apligraf and systemic immunosuppressive agents.
    Duchini G; Itin P; Arnold A
    Adv Skin Wound Care; 2011 May; 24(5):217-20. PubMed ID: 21505282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A non-infectious pyodermatitis: Pyoderma gangrenosum].
    Lambert J; Jonlet F; Vanhooteghem O; Richert B; de la Brassinne M
    Rev Med Liege; 2001 Feb; 56(2):106-11. PubMed ID: 11294044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis and novel clinical treatment strategies for pyoderma gangrenosum.
    Goldust M; Hagstrom EL; Rathod D; Ortega-Loayza AG
    Expert Rev Clin Pharmacol; 2020 Feb; 13(2):157-161. PubMed ID: 31875484
    [No Abstract]   [Full Text] [Related]  

  • 12. UK Dermatology Clinical Trials Network's STOP GAP trial (a multicentre trial of prednisolone versus ciclosporin for pyoderma gangrenosum): protocol for a randomised controlled trial.
    Craig FF; Thomas KS; Mitchell EJ; Williams HC; Norrie J; Mason JM; Ormerod AD;
    Trials; 2012 Apr; 13():51. PubMed ID: 22540770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pyoderma gangrenosum: a systematic review.
    Cozzani E; Gasparini G; Parodi A
    G Ital Dermatol Venereol; 2014 Oct; 149(5):587-600. PubMed ID: 25213386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The safety of treatments used in pyoderma gangrenosum.
    Feldman SR; Lacy FA; Huang WW
    Expert Opin Drug Saf; 2018 Jan; 17(1):55-61. PubMed ID: 29065721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Etiology and management of pyoderma gangrenosum: a comprehensive review.
    Ahronowitz I; Harp J; Shinkai K
    Am J Clin Dermatol; 2012 Jun; 13(3):191-211. PubMed ID: 22356259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of Pyoderma Gangrenosum.
    Tan MG; Tolkachjov SN
    Dermatol Clin; 2024 Apr; 42(2):183-192. PubMed ID: 38423680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Extensive ulcerations in children: The difficulty diagnosing pyoderma gangrenosum].
    Ramli I; Rachadi H; Amarouch H; Rimani M; Senouci K; Benzekri L; Hassam B
    Arch Pediatr; 2015 Jul; 22(7):753-5. PubMed ID: 26047747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pyoderma gangrenosum--rebel without a cure?
    Jacob SE; Weisman RS; Kerdel FA
    Int J Dermatol; 2008 Feb; 47(2):192-4. PubMed ID: 18211497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pyoderma gangrenosum: classification and management.
    Powell FC; Su WP; Perry HO
    J Am Acad Dermatol; 1996 Mar; 34(3):395-409; quiz 410-2. PubMed ID: 8609250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Case Report: Triple Combination Therapy for Recalcitrant Perineal Pyoderma Gangrenosum.
    Shaath TS; Om A; Wolfe CM; Cohen GF
    J Drugs Dermatol; 2019 Mar; 18(3):307-310. PubMed ID: 31020825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.